Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gleave

Showing results (51-60 of 258) with videos related to

Pageof 26
Sort By:
Cancer Research|December 3, 2005
Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosisPalma Rocchi, Eliana Beraldi, Susan Ettinger, et al.
Cancer Medicine|October 25, 2013
Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsenBrent Blumenstein, Fred Saad, Sebastien Hotte, et al.
Cancer Research|November 3, 2007
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activityAmina Zoubeidi, Anousheh Zardan, Eliana Beraldi, et al.
Oncotarget|August 21, 2014
Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcomaFrancois Lamoureux, Marc Baud'huin, Benjamin Ory, et al.
BJU International|August 2, 2006
Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitroPalma Rocchi, Paul Jugpal, Alan So, et al.
Cells|July 14, 2023
Dependency of Tamoxifen Sensitive and Resistant ER<sup>+</sup> Breast Cancer Cells on Semaphorin 3C (SEMA3C) for GrowthSatyam Bhasin, Christopher Dusek, James W Peacock, et al.
Cancer Research|June 22, 2013
Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR StabilityHiroaki Matsumoto, Yoshiaki Yamamoto, Masaki Shiota, et al.
Biochimica Et Biophysica Acta|December 6, 2011
Apo J/clusterin expression and secretion: evidence for 15-deoxy-Δ(12,14)-PGJ(2)-dependent mechanismDamien Gates, Kiera Dollin, Roisin Connolly, et al.
Computers in Biology and Medicine|October 30, 2020
Improving prostate cancer classification in H&E tissue micro arrays using Ki67 and P63 histopathologyYanan Shao, Guy Nir, Ladan Fazli, et al.
Nuclear Medicine and Biology|November 26, 2008
Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticalsCara L Ferreira, Donald T Yapp, Eric Lamsa, et al.
Pageof 26

Showing results (51-60 of 258) with videos related to

Sort By:
Pageof 26
Cancer Research|December 3, 2005
Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosisPalma Rocchi, Eliana Beraldi, Susan Ettinger, et al.
Cancer Medicine|October 25, 2013
Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsenBrent Blumenstein, Fred Saad, Sebastien Hotte, et al.
Cancer Research|November 3, 2007
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activityAmina Zoubeidi, Anousheh Zardan, Eliana Beraldi, et al.
Oncotarget|August 21, 2014
Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcomaFrancois Lamoureux, Marc Baud'huin, Benjamin Ory, et al.
BJU International|August 2, 2006
Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitroPalma Rocchi, Paul Jugpal, Alan So, et al.
Cells|July 14, 2023
Dependency of Tamoxifen Sensitive and Resistant ER<sup>+</sup> Breast Cancer Cells on Semaphorin 3C (SEMA3C) for GrowthSatyam Bhasin, Christopher Dusek, James W Peacock, et al.
Cancer Research|June 22, 2013
Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR StabilityHiroaki Matsumoto, Yoshiaki Yamamoto, Masaki Shiota, et al.
Biochimica Et Biophysica Acta|December 6, 2011
Apo J/clusterin expression and secretion: evidence for 15-deoxy-Δ(12,14)-PGJ(2)-dependent mechanismDamien Gates, Kiera Dollin, Roisin Connolly, et al.
Computers in Biology and Medicine|October 30, 2020
Improving prostate cancer classification in H&E tissue micro arrays using Ki67 and P63 histopathologyYanan Shao, Guy Nir, Ladan Fazli, et al.
Nuclear Medicine and Biology|November 26, 2008
Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticalsCara L Ferreira, Donald T Yapp, Eric Lamsa, et al.
Pageof 26